The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks

European Urology

Volumn 70, Issue 3, 2016, Pages 458-466

  Cumberbatch, Marcus G ^a   Rota, Matteo ^b   Catto, James W F ^a   La Vecchia, Carlo ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bladder cancer; Kidney cancer; Tobacco smoking

Indexed keywords

TOBACCO SMOKE;

BEGG TEST; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CARCINOGENESIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; EGGER TEST; EXPOSURE; HIGH RISK POPULATION; HUMAN; KIDNEY CANCER; META ANALYSIS; MORTALITY RISK; PASSIVE SMOKING; PRIORITY JOURNAL; PUBLISHING; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING CESSATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYSTEMATIC REVIEW; BLADDER TUMOR; KIDNEY TUMOR; MORTALITY; RENAL CELL CARCINOMA;

CARCINOGENESIS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; TOBACCO SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84936972817     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.06.042     Document Type: Review

References (45)

1. [1] Islami, F., Stoklosa, M., Drope, J., Jemal, A., Global and regional patterns of tobacco smoking and tobacco control policies. Eur Urol Focus 1 (2015), 3–16.
2. [2] Samanic, C., Kogevinas, M., Dosemeci, M., et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 15 (2006), 1348–1354.
3. [3] Zheng, Y.L., Amr, S., Saleh, D.A., et al. Urinary bladder cancer risk factors in Egypt: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev 21 (2012), 537–546.
4. [4] De Stefani, E., Correa, P., Fierro, L., Fontham, E., Chen, V., Zavala, D., Black tobacco, mate, and bladder cancer. A case-control study from Uruguay. Cancer 67 (1991), 536–540.
5. [5] Momas, I., Daures, J.P., Festy, B., Bontoux, J., Gremy, F., Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 10 (1994), 599–604.
6. [6] Burger, M., Catto, J.W., Dalbagni, G., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63 (2013), 234–241.
7. [7] Borzym-Kluczyk, M., Radziejewska, I., Zaniewska, A., et al. Effect of smoking on activity of N-acetyl-beta-hexosaminidase in serum and urine of renal cancer patients. Clin Biochem 42 (2009), 1565–1567.
8. [8] Rouissi, K., Ouerhani, S., Hamrita, B., et al. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res 17 (2011), 879–886.
9. [9] Chavan, S., Bray, F., Lortet-Tieulent, J., Goodman, M., Jemal, A., International variations in bladder cancer incidence and mortality. Eur Urol 66 (2014), 59–73.
10. [10] Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A., Bray, F., International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 67 (2015), 519–530.
11. [11] Benichou, J., Chow, W.H., McLaughlin, J.K., Mandel, J.S., Fraumeni, J.F. Jr., Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 148 (1998), 424–430.
12. [12] Chu, H., Wang, M., Zhang, Z., Bladder cancer epidemiology and genetic susceptibility. J Biomed Res 27 (2013), 170–178.
13. [13] Lammers, R.J., Witjes, W.P., Hendricksen, K., Caris, C.T., Janzing-Pastors, M.H., Witjes, J.A., Smoking status is a risk factor for recurrence after transurethral resection of non–muscle-invasive bladder cancer. Eur Urol 60 (2011), 713–720.
14. [14] Lee, C., Kim, K.H., You, D., et al. Smoking and survival after radical cystectomy for bladder cancer. Urology 80 (2012), 1307–1312.
15. [15] Sfakianos, J.P., Shariat, S.F., Favaretto, R.L., Rioja, J., Herr, H.W., Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder. BJU Int 108 (2011), 526–530.
16. [16] Maclure, M., Katz, R.B., Bryant, M.S., Skipper, P.L., Tannenbaum, S.R., Elevated blood levels of carcinogens in passive smokers. Am J Public Health 79 (1989), 1381–1384.
17. [17] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, 2009, e1000097.
18. [18] Greenland, S., Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9 (1987), 1–30.
19. [19] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
20. [20] Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558.
21. [21] Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
22. [22] Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
23. [23] Marcus, P.M., Hayes, R.B., Vineis, P., et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 9 (2000), 461–467.
24. [24] Stern, M.C., Lin, J., Figueroa, J.D., et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 69 (2009), 6857–6864.
25. [25] Pelucchi, C., Bosetti, C., Negri, E., Malvezzi, M., La Vecchia, C., Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 3 (2006), 327–340.
26. [26] Gabriel, U., Li, L., Bolenz, C., et al. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer. Mol Carcinog 51 (2012), 907–915.
27. [27] Rothman, N., Garcia-Closas, M., Chatterjee, N., et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42 (2010), 978–984.
28. [28] Hunt, J.D., van der Hel, O.L., McMillan, G.P., Boffetta, P., Brennan, P., Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114 (2005), 101–108.
29. [29] Corrao, G., Scotti, L., Bagnardi, V., Sega, R., Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis. Curr Drug Saf 2 (2007), 125–133.
30. [30] Purdue, M.P., Moore, L.E., Merino, M.J., et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132 (2013), 2640–2647.
31. [31] World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2007, AICR, Washington, DC.
32. [32] McLaughlin, J.K., Lipworth, L., Tarone, R.E., Epidemiologic aspects of renal cell carcinoma. Semin Oncol 33 (2006), 527–533.
33. [33] Parker, A., Lohse, C., Cheville, J., Leibovich, B., Igel, T., Blute, M., Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol 15 (2008), 304–308.
34. [34] Setiawan, V.W., Stram, D.O., Nomura, A.M., Kolonel, L.N., Henderson, B.E., Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166 (2007), 932–940.
35. [35] Underwood, J.M., Townsend, J.S., Tai, E., White, A., Davis, S.P., Fairley, T.L., Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. J Cancer Surviv 6 (2012), 333–344.
36. [36] Shiels, M.S., Gibson, T., Sampson, J., et al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol 32 (2014), 3989–3995.
37. [37] Kauffman, E.C., Ricketts, C.J., Rais-Bahrami, S., et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11 (2014), 465–475.
38. [38] Theis, R.P., Dolwick Grieb, S.M., Burr, D., Siddiqui, T., Asal, N.R., Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study. BMC Cancer, 8, 2008, 387.
39. [39] Moher, D., Pham, B., Klassen, T.P., et al. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 53 (2000), 964–972.
40. [40] Sweeney, C., Farrow, D.C., Differential survival related to smoking among patients with renal cell carcinoma. Epidemiology 11 (2000), 344–346.
41. [41] Siemiatycki, J., Dewar, R., Krewski, D., Desy, M., Richardson, L., Franco, E., Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures?. Epidemiology 5 (1994), 57–65.
42. [42] Ernster, V.L., Trends in smoking, cancer risk, and cigarette promotion. Current priorities for reducing tobacco exposure. Cancer 62 (1988), 1702–1712.
43. [43] Bosetti, C., Bertuccio, P., Malvezzi, M., et al. Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol 24 (2013), 2657–2671.
44. [44] Levi, F., Ferlay, J., Galeone, C., et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101 (2008), 949–958.
45. [45] Strope, S.A., Montie, J.E., The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 180 (2008), 31–37.